Chugai Pharmaceutical Co Ltd PharmaVitae Profile

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Japan Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

Japan Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

  • $ 5 400
  • Industry report
  • by Venture Planning Group
  • July 2014
  • 620 pages

This new study from Venture Planning Group contains 620 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.Complete report $5,400.  DataPack ...

Industries: In Vitro Diagnostic | Countries: Japan

Global Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

Global Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

  • $ 19 500
  • Industry report
  • by Venture Planning Group
  • July 2014
  • 775 pages

This new seven-country study from Venture Planning Group contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Complete report ...

Industries: In Vitro Diagnostic | Countries: World, United States, Spain, Italy, France, Germany, Japan

Techno Medica Co., Ltd. (Symbol:6678) SWOT Analysis, Strategy, Revenues and Profits

Techno Medica Co., Ltd. (Symbol:6678) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • June 2014
  • 27 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Techno Medica Co., Ltd. SWOT Analysis report provides you a strategic ...

Industries: In Vitro Diagnostic | Countries: Japan

Sysmex Corporation (6869) - Product Pipeline Analysis, 2014 Update

Sysmex Corporation (6869) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • June 2014
  • 35 pages

Summary Sysmex Corporation (Sysmex) is a medical device company. It undertakes research, development, manufacturing and sale of instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. Sysmex also explores wide range of opportunities in the life ...

Industries: In Vitro Diagnostic | Countries: Germany, Japan, United States, World, Singapore

Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

  • $ 15 900
  • Industry report
  • by Venture Planning Group
  • June 2014
  • 1200 pages

"Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence" is Venture Planning Group's new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The ...

Industries: In Vitro Diagnostic | Countries: France, Germany, Japan, Italy, Spain, Europe, World

Tumor Markers: Unlocking the Mistery of the Genetic Basis of Cancer--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

Tumor Markers: Unlocking the Mistery of the Genetic Basis of Cancer--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

  • $ 15 900
  • Industry report
  • by Venture Planning Group
  • June 2014
  • 1200 pages

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years - Examines trends in the U.S., Europe and Japan - Reviews current and emerging tumor markers - Analyzes applications of emerging diagnostic technologies - Forecasts sales of ...

Industries: In Vitro Diagnostic | Countries: Japan, World, United States, Europe, Spain, Italy, France, Germany

Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Business and Corporate Strategies--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Business and Corporate Strategies--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

  • $ 15 900
  • Industry report
  • by Venture Planning Group
  • June 2014
  • 1050 pages

This new seven-country study from Venture Planning Group contains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Highlights - Business ...

Industries: In Vitro Diagnostic | Countries: United States, Japan, World, Spain, Italy, France, Germany

Nucleic Acid Testing: Infectious Diseases, Cancer, Genetic Diseases, Forensic Testing, Paternity Testing/HLA Typing--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

Nucleic Acid Testing: Infectious Diseases, Cancer, Genetic Diseases, Forensic Testing, Paternity Testing/HLA Typing--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

  • $ 15 900
  • Industry report
  • by Venture Planning Group
  • June 2014
  • 1050 pages

This unique seven-country, 1,050-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. Highlights - Business and technological trends in seven major markets - Five- and ten-yea ...

Industries: In Vitro Diagnostic | Countries: United States, World, Japan

Coagulation Testing in Transition: Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside

Coagulation Testing in Transition: Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside

  • $ 15 900
  • Industry report
  • by Venture Planning Group
  • June 2014
  • 650 pages

"Coagulation Testing in Transition: Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside" is Venture Planning Group's new seven-country report designed to help current suppliers and potential market entrants identify ...

Industries: In Vitro Diagnostic | Countries: Spain, Germany, United States, Italy, France, Japan, Europe, World

Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges--Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market

Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges--Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market

  • $ 15 900
  • Industry report
  • by Venture Planning Group
  • June 2014
  • 700 pages

Complete report $24,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900. "Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges--Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will ...

Industries: In Vitro Diagnostic | Countries: Spain, France, Germany, Italy, Japan, United States, Europe, World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.